Search results
Gene editing company
- Horizon Discovery Group plc (LSE: HZD) ("Horizon"), is a gene editing company that designs and engineers genetically modified cells and then applies them in research and clinical applications in human health.
en.wikipedia.org/wiki/Horizon_Discovery
People also ask
Who is Horizon Discovery Group plc?
What is Horizon Discovery?
Did PerkinElmer buy Horizon Discovery?
What are some alternatives to Horizon Discovery?
Horizon Discovery Group plc (LSE: HZD) ("Horizon"), [2] is a gene editing company that designs and engineers genetically modified cells and then applies them in research and clinical applications in human health.
Horizon Discovery drives the application of gene editing and gene modulation to enable world-leading academic institutes, pharmaceutical and biotechnology companies, as well as clinical diagnostic laboratories, to identify the genetic drivers behind human disease, develop and validate diagnostic workflows, and deliver new therapies for ...
Developer of a gene-editing platform designed to enable scientists to genetically modify cells. The company's products and services include bioproduction cell lines, downstream analysis, gene editing, non-mammalian research, immune cell screening, cell panel screening and more.
- 416
- Co-Founder
Horizon Discovery Group PLC is a UK life science company that uses gene editing and gene modulation platforms to produce cells, applying them in research and clinical applications that advance human health.
- Cambridge, Cambridgeshire
- Horizon Discovery is located in Cambridge, Cambridgeshire, United Kingdom.
- Horizon Discovery has 15 investors including ValueAct Capital And Future Fifty.
- Horizon Discovery has raised $38.5M.
- Horizon Discovery closed its last funding round on Sep 7, 2018 from a Post-IPO Equity round.
- Alternatives and possible competitors to Horizon Discovery may include Human Longevity, Oxford BioMedica, And NGM Biopharmaceuticals.
Nov 2, 2020 · Horizon Discovery Group plc (LSE: HZD) ("Horizon") is a cell engineering company focused on commercializing the application of gene editing and gene modulation to accelerate scientific...
Horizon Discovery, formerly of PerkinElmer, and now part of the Revvity family, drives the application of gene editing and gene modulation to enable world-leading academic institutes,...
Horizon Discovery, formerly of PerkinElmer, and now part of the Revvity family, drives the application of gene editing and gene modulation to enable world-leading academic institutes,...
